sysa1801
cspc pharmaceuticals,elevation oncology
['eo-3021', 'elevation oncology']
the elevation team is wrapping up a successful trip to #asco2023, where our partner presented new clinical data on eo-3021 showing promising signs of efficacy. see the presentation here: #asco #asco23 
We are focused on discovering and developing selective cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs.